ArticleWearable technologies2025
Effectiveness of a trunk-wearable neuromuscular electrical stimulation device in postpartum women with diastasis rectus abdominis: A prospective randomized controlled trial.
Article in Wearable technologies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diastasis of rectus abdominis (DRA) is a common pathological condition in postpartum rehabilitation, but with limited treatment strategies. This study aimed to explore the effect of using a trunk-wearable neuromuscular electrical stimulation (NMES) device on postpartum women with moderate and severe DRA. A total of 84 postpartum women with an inter-rectus distance (IRD) of ≥3 cm were randomly assigned to two equal groups. The treatment group received a trunk-wearable NMES device and exercise therapy, whereas the control group received exercise only. We measured IRD and calculated treatment response proportion, improvement of trunk muscle strength, and low-back pain in both groups. Additionally, we evaluated quality of life (QoL) using the SF-36 questionnaire and Hernia-related Quality of Life Survey (HerQLes). Statistical analysis was performed using SAS 9.4. After 8-week treatment, the IRD of the umbilical (M3) sector showed a greater reduction in the treatment group (-10.6 [-17.9 to -3.3]%,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.